AVEANNA HEALTHCARE HOLDINGS (AVAH) Stock Fundamental Analysis
USA - NASDAQ:AVAH - US05356F1057 - Common Stock
9.86 USD
+0.05 (+0.51%)
9.67 USD
-0.19 (-1.93%)
AVAH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While AVAH is still in line with the averages on profitability rating, there are concerns on its financial health. AVAH has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year AVAH was profitable.
AVAH had a positive operating cash flow in the past year.
AVAH had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AVAH reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of 1.05%, AVAH perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
AVAH has a better Return On Invested Capital (12.61%) than 88.12% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AVAH is below the industry average of 9.34%.
The 3 year average ROIC (5.94%) for AVAH is below the current ROIC(12.61%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.05% | ||
| ROE | N/A | ||
| ROIC | 12.61% |
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
1.3 Margins
AVAH's Profit Margin of 0.85% is in line compared to the rest of the industry. AVAH outperforms 54.46% of its industry peers.
AVAH has a Operating Margin of 9.95%. This is in the better half of the industry: AVAH outperforms 78.22% of its industry peers.
AVAH's Operating Margin has improved in the last couple of years.
AVAH's Gross Margin of 33.33% is fine compared to the rest of the industry. AVAH outperforms 61.39% of its industry peers.
AVAH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.95% | ||
| PM (TTM) | 0.85% | ||
| GM | 33.33% |
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AVAH is creating some value.
Compared to 1 year ago, AVAH has more shares outstanding
Compared to 5 years ago, AVAH has more shares outstanding
Compared to 1 year ago, AVAH has an improved debt to assets ratio.
2.2 Solvency
AVAH has an Altman-Z score of 1.28. This is a bad value and indicates that AVAH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.28, AVAH is not doing good in the industry: 68.32% of the companies in the same industry are doing better.
AVAH has a debt to FCF ratio of 18.43. This is a negative value and a sign of low solvency as AVAH would need 18.43 years to pay back of all of its debts.
With a Debt to FCF ratio value of 18.43, AVAH perfoms like the industry average, outperforming 41.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 18.43 | ||
| Altman-Z | 1.28 |
ROIC/WACC1.2
WACC10.48%
2.3 Liquidity
A Current Ratio of 1.09 indicates that AVAH should not have too much problems paying its short term obligations.
AVAH has a worse Current ratio (1.09) than 68.32% of its industry peers.
A Quick Ratio of 1.09 indicates that AVAH should not have too much problems paying its short term obligations.
AVAH has a Quick ratio of 1.09. This is in the lower half of the industry: AVAH underperforms 63.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 600.00% over the past year.
The earnings per share for AVAH have been decreasing by -49.58% on average. This is quite bad
AVAH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.54%.
The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)600%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%1700%
Revenue 1Y (TTM)11.54%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%16.75%
3.2 Future
Based on estimates for the next years, AVAH will show a very strong growth in Earnings Per Share. The EPS will grow by 131.73% on average per year.
The Revenue is expected to grow by 8.97% on average over the next years. This is quite good.
EPS Next Y792.62%
EPS Next 2Y220.75%
EPS Next 3Y131.73%
EPS Next 5YN/A
Revenue Next Year15.26%
Revenue Next 2Y10.88%
Revenue Next 3Y8.97%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 28.17, AVAH can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as AVAH.
AVAH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.76.
AVAH is valuated rather expensively with a Price/Forward Earnings ratio of 19.17.
AVAH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AVAH is cheaper than 66.34% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, AVAH is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.17 | ||
| Fwd PE | 19.17 |
4.2 Price Multiples
AVAH's Enterprise Value to EBITDA ratio is in line with the industry average.
AVAH's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.23 | ||
| EV/EBITDA | 15.72 |
4.3 Compensation for Growth
AVAH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AVAH's earnings are expected to grow with 131.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y220.75%
EPS Next 3Y131.73%
5. Dividend
5.1 Amount
AVAH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
9.86
+0.05 (+0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners19.39%
Inst Owner Change0.43%
Ins Owners5.67%
Ins Owner Change4.53%
Market Cap2.06B
Revenue(TTM)2.18B
Net Income(TTM)18.55M
Analysts76
Price Target8.83 (-10.45%)
Short Float %7.5%
Short Ratio3.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3684.14%
Min EPS beat(2)412.4%
Max EPS beat(2)6955.89%
EPS beat(4)4
Avg EPS beat(4)2421.48%
Min EPS beat(4)256.86%
Max EPS beat(4)6955.89%
EPS beat(8)7
Avg EPS beat(8)1235.02%
EPS beat(12)9
Avg EPS beat(12)807.07%
EPS beat(16)9
Avg EPS beat(16)598.72%
Revenue beat(2)2
Avg Revenue beat(2)7.41%
Min Revenue beat(2)6.85%
Max Revenue beat(2)7.96%
Revenue beat(4)4
Avg Revenue beat(4)4.36%
Min Revenue beat(4)0.61%
Max Revenue beat(4)7.96%
Revenue beat(8)7
Avg Revenue beat(8)2.61%
Revenue beat(12)9
Avg Revenue beat(12)1.59%
Revenue beat(16)10
Avg Revenue beat(16)0.12%
PT rev (1m)4.13%
PT rev (3m)48.13%
EPS NQ rev (1m)13.07%
EPS NQ rev (3m)147.16%
EPS NY rev (1m)0.77%
EPS NY rev (3m)114.03%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)7.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.17 | ||
| Fwd PE | 19.17 | ||
| P/S | 0.95 | ||
| P/FCF | 26.23 | ||
| P/OCF | 24.02 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.72 |
EPS(TTM)0.35
EY3.55%
EPS(NY)0.51
Fwd EY5.22%
FCF(TTM)0.38
FCFY3.81%
OCF(TTM)0.41
OCFY4.16%
SpS10.42
BVpS-0.05
TBVpS-5.86
PEG (NY)0.04
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.05% | ||
| ROE | N/A | ||
| ROCE | 15.97% | ||
| ROIC | 12.61% | ||
| ROICexc | 13.63% | ||
| ROICexgc | 399.63% | ||
| OM | 9.95% | ||
| PM (TTM) | 0.85% | ||
| GM | 33.33% | ||
| FCFM | 3.61% |
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
ROICexc(3y)6.24%
ROICexc(5y)5.39%
ROICexgc(3y)148.4%
ROICexgc(5y)163.95%
ROCE(3y)7.54%
ROCE(5y)6.51%
ROICexgc growth 3Y3.46%
ROICexgc growth 5Y50.58%
ROICexc growth 3Y35.54%
ROICexc growth 5Y22.27%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
F-Score8
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 18.43 | ||
| Debt/EBITDA | 5.88 | ||
| Cap/Depr | -1158.75% | ||
| Cap/Sales | 0.33% | ||
| Interest Coverage | 1.5 | ||
| Cash Conversion | 39.69% | ||
| Profit Quality | 423.16% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 1.28 |
F-Score8
WACC10.48%
ROIC/WACC1.2
Cap/Depr(3y)53.12%
Cap/Depr(5y)65.29%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)600%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%1700%
EPS Next Y792.62%
EPS Next 2Y220.75%
EPS Next 3Y131.73%
EPS Next 5YN/A
Revenue 1Y (TTM)11.54%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%16.75%
Revenue Next Year15.26%
Revenue Next 2Y10.88%
Revenue Next 3Y8.97%
Revenue Next 5YN/A
EBIT growth 1Y82.83%
EBIT growth 3Y14.38%
EBIT growth 5Y18.06%
EBIT Next Year83.91%
EBIT Next 3Y27.57%
EBIT Next 5YN/A
FCF growth 1Y349.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y488.65%
OCF growth 3YN/A
OCF growth 5YN/A
AVEANNA HEALTHCARE HOLDINGS / AVAH FAQ
What is the ChartMill fundamental rating of AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?
ChartMill assigns a fundamental rating of 4 / 10 to AVAH.
What is the valuation status of AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?
ChartMill assigns a valuation rating of 4 / 10 to AVEANNA HEALTHCARE HOLDINGS (AVAH). This can be considered as Fairly Valued.
How profitable is AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?
AVEANNA HEALTHCARE HOLDINGS (AVAH) has a profitability rating of 4 / 10.
Can you provide the financial health for AVAH stock?
The financial health rating of AVEANNA HEALTHCARE HOLDINGS (AVAH) is 2 / 10.